Milk Hypersensitivity clinical trials
The registry lists 147 studies for Milk Hypersensitivity across more than 10 countries. 26 are recruiting or about to start. 117 of them are mainly about Milk Hypersensitivity (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.
Get an email when these change. Save the Milk Hypersensitivity studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Federico II University (18) · Société des Produits Nestlé (SPN) (9) · United Pharmaceuticals (6) · Assiut University (5) · National Institute of Allergy and Infectious Diseases (NIAID) (4) · Nutricia UK Ltd (4) · Ain Shams University (3) · Medical University of Warsaw (3)
What is being tested here
Drugs under test in Milk Hypersensitivity studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Remibrutinib | 1 | 1 | 1 |
| cow's milk | 0 | 0 | 4 |
| Lacticaseibacillus rhamnosus GG | 0 | 0 | 3 |
| Milk Proteins | 0 | 0 | 3 |
| Omalizumab | 0 | 0 | 2 |
| Ozureprubart | 0 | 0 | 1 |
| Dupilumab | 0 | 0 | 1 |
| Cizutamig | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 7, phase 3 first
- Apr 2027Comparison Between a Rush and a Conventional Oral Immunotherapy Protocol to Treat Cow's Milk and Hen´s Egg Allergy. CompITO Study · Phase 3 · Pablo Rodríguez del Rio
- Nov 2026Evaluation of the Tolerance of a New Formula Based on Hydrolyzed Rice Proteins in Children With Cow's Milk Allergy · Health and Happiness Research Limited
- Dec 2026Nutritional Evaluation of Infants Receiving Amino Acid-Based Formula · Assiut University
- Jan 2027A Long Term, Observational Follow-Up Study of Children and Young People Who Underwent an 18-Month Course of Oral Immunotherapy Treatment for Peanut, Egg or Milk Allergy (5-15 Years Post-Treatment) · Murdoch Childrens Research Institute
- Feb 2027Goat vs. Cow Milk Digestive Tolerance · Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
- Mar 2027Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy · RAPT Therapeutics, Inc., a member of the GSK plc group of companies
- Jul 2027Hydrolysed Rice Formula Study · Nutricia UK Ltd
Who these studies take
Of the 17 Milk Hypersensitivity studies recruiting now, 1 (6%) set no upper age limit and 16 (94%) stop at 75 or younger. 16 (94%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (6%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 8 (47%) | 8 (47%) |
| 18 | 6 (35%) | 6 (35%) |
| 30 | 4 (24%) | 4 (24%) |
| 40 | 4 (24%) | 4 (24%) |
| 50 | 3 (18%) | 3 (18%) |
| 65 | 3 (18%) | 3 (18%) |
| 75 | 1 (6%) | 1 (6%) |
| 85 | 1 (6%) | 1 (6%) |
Across all 147 studies, recruiting or not: 95% stop at 75 or younger and 94% at 65; 94% take children; 0% are for women only and 0% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Milk Hypersensitivity studies take
Of 34 interventional studies with no phase under Milk Hypersensitivity, half reached primary completion within 30 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 30 mo17–48 · 34 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 13, 2026.
Newly registered1
Studies
Recruiting first, then most recently updated. Showing 50 of 147. Browse all 147 → or search them.
- A 52-week Study of Remibrutinib in IgE-mediated Food AllergyRecruitingNCT07768371Phase 31 country
- Evaluation of the Tolerance of a New Formula Based on Hydrolyzed Rice Proteins in Children With Cow's Milk AllergyRecruitingNCT07197814Not applicable1 country
- Performance of the Basophil Activation Test in the Diagnosis of IgE-mediated Cow's Milk Allergy in Infants and Evaluation of Hydrolysate Allergenicity.Not yet recruitingNCT07900594Not applicable
- Infant Formula in Infants and Children With Cow's Milk AllergyRecruitingNCT06456541Not applicable1 country
- TeriFort 1+ Study: Efficacy and Safety of an Extensively Hydrolyzed Formula in the Management of Cow's Milk Protein Allergy in Young Children: A Prospective, Single-Arm Interventional Study (TeriFort 1+)Not yet recruitingNCT07855796Not applicable1 country
- Pasteurised Donor Human Milk Supplementation for Term BabiesRecruitingNCT06993103Phase 41 country
- GOAt Milk Formula-based Ladder Versus Cow's Milk LadderNot yet recruitingNCT07795957Not applicable1 country
- Dietary Restriction Efficiency Assessment in CMPANot yet recruitingNCT07199023Not applicable
- Oral Immunotherapy for Children With Cow's Milk AllergyNot yet recruitingNCT07768696Not applicable1 country
- Stepwise Heat-Denaturated Protein Introduction for Tolerance Induction in Food AllergyRecruitingNCT06380673Not applicable1 country
- Investigating Modified Protocols of Oral Immunotherapy to Validate Efficacy and SafetyRecruitingNCT06256146Not applicable1 country
- Hydrolysed Rice Formula StudyRecruitingNCT06288503Not applicable1 country
- Safety and Efficacy Evaluation of an Extensively Hydrolyzed Formula in Infants With Cow's Milk Protein Allergy (CMPA)Not yet recruitingNCT07484035Not applicable1 country
- Post-failure Stepwise Heat-Denaturated Protein Introduction for Tolerance Induction in Cow's Milk Allergy Observational Cohort StudyRecruitingNCT074487401 country
- Comparison Between a Rush and a Conventional Oral Immunotherapy Protocol to Treat Cow's Milk and Hen´s Egg Allergy. CompITO StudyRecruitingNCT06976775Phase 2/31 country
- A Long Term, Observational Follow-Up Study of Children and Young People Who Underwent an 18-Month Course of Oral Immunotherapy Treatment for Peanut, Egg or Milk Allergy (5-15 Years Post-Treatment)RecruitingNCT073591831 country
- SMASH: Study to Evaluate the Clinical Efficacy of an Extensively Hydrolysed Infant Formula With Synbiotics and a Human Milk Oligosaccharide (HMO) in Infants With Cow's Milk Protein Allergy (CMPA)RecruitingNCT073426211 country
- Goat vs. Cow Milk Digestive ToleranceRecruitingNCT07239856Not applicable1 country
- Nutritional Evaluation of Infants Receiving Amino Acid-Based FormulaNot yet recruitingNCT071749991 country
- Validation Of A Parent Administered Symptom Score For Unsettled Infants (Every Baby is UnIQue)Not yet recruitingNCT071210621 country
- Early Supplementation for Cow's Milk Allergy PreventionNot yet recruitingNCT06652698Not applicable1 country
- Effectiveness and Safety of Milk Ladders in Children with IgE-Mediated Cow's Milk Protein AllergyRecruitingNCT06664918Not applicable1 country
- Clinical Versus Home Introduction of Milk in Children with Non-IgE-mediated Cow's Milk AllergyRecruitingNCT05785299Not applicable1 country
- The Clinical Impact of the Basophil Activation Test to Diagnose Food AllergyRecruitingNCT05309772Not applicable1 country
- Validity of Cow's Milk-related Symptom Score Among Children Suspected to Have Cow's Milk Protein AlergyRecruitingNCT058833841 country
- BAT Cow's Milk for the Replacement of the Food Challenge TestRecruitingNCT050649171 country
- Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food AllergyActive, not recruitingNCT07220811Phase 23 countries
- Epigenetic Effects Elicited By Lactobacillus GG In Children With Cow's Milk AllergyCompletedNCT02062476Not applicable1 country
- Microbiota as Potential Target for Food AllergyCompletedNCT020879301 country
- A Phase 1 Study of Cizutamig in IgE Mediated DiseasesWithdrawnNCT07408869Phase 11 country
- Hypoallergenicity of a Hydrolyzed Rice Protein-based Formula in Infants and Young Children With Cow's Milk Protein AllergyCompletedNCT06633289Not applicable3 countries
- Epigenetic Effects in Children With Cow's Milk Allergy Treated With Different FormulasCompletedNCT04184700Not applicable1 country
- Human Breast Milk's Role in Food Allergy DevelopmentWithdrawnNCT06765213
- Dupilumab and Milk OIT for the Treatment of Cow's Milk AllergyTerminatedNCT04148352Phase 21 country
- Sublingual Milk Immunotherapy in ChildrenCompletedNCT00874627Not applicable1 country
- Growth, Safety and Tolerance of a Hydrolyzed Protein Infant FormulaCompletedNCT05618704Not applicable1 country
- Partially Hydrolyzed Formula in Cow's Milk Protein Allergy After 6 Months of EliminationCompletedNCT06130085Not applicable1 country
- Testing Tolerance in Cow Milk Protein Allergy Patients: Milk Ladder or Direct Milk Administration?CompletedNCT05960045Not applicable1 country
- The Frequency of Beef Allergy in Children With Cow Milk AllergyCompletedNCT05943704Not applicable1 country
- Synbiotics Cohort StudyTerminatedNCT050464181 country
- Baked Milk Oral Immunotherapy for Cow's Milk AllergyCompletedNCT03462030Phase 21 country
- Evaluation of Tolerance, Efficacy and Safety of an Hydrolyzed Formula in Infants With IgE/Non-IgE Mediated CMA.Active, not recruitingNCT06481280Not applicable2 countries
- The Incidence of Venous Thromboembolism in Atopic DermatitisCompletedNCT049696531 country
- Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk AllergyCompletedNCT02223182Phase 1/22 countries
- Hypoallergenicity of a New Formula in Subjects With Cow's Milk AllergyCompletedNCT06134466Not applicable1 country
- Association of Renal-tubular Acidosis in Children With Cow Milk Protein AllergyCompletedNCT064948521 country
- Dietary Choice for the Management of Cow's Milk Allergy Influences Other Allergic ManifestationsCompletedNCT038619101 country
- ADP101 for Oral Immunotherapy in Food-Allergic Children and AdultsCompletedNCT04856865Phase 1/21 country
- Hypoallergenicity of a Hydrolyzed Protein Infant FormulaSuspendedNCT05731206Not applicable1 country
- Detection of Metabolite Biomarkers for the Early Diagnosis and Prognosis of Cow's Milk Allergy in ChildrenActive, not recruitingNCT042499731 country